We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 21-40 of 921 results
  1. JMJD1C-mediated metabolic dysregulation contributes to HOXA9-dependent leukemogenesis

    Abnormal metabolism is a fundamental hallmark of cancer and represents a therapeutic opportunity, yet its regulation by oncogenes remains poorly...

    Jennifer R. Lynch, Basit Salik, ... Jenny Y. Wang in Leukemia
    Article 08 January 2019
  2. A C/ebpα isoform specific differentiation program in immortalized myelocytes

    The transcription factor CCAAT-enhancer binding factor alpha (C/ebpα) is a master controller of myeloid differentiation that is expressed as long...

    Maria-Paz Garcia-Cuellar, Selin Akan, Robert K. Slany in Leukemia
    Article Open access 02 August 2023
  3. Successful use of Palbociclib combined with Venetoclax and Azacitidine in an adult with refractory/relapsed therapy-related acute myeloid leukemia

    Background

    Therapy-related acute myeloid leukemia (t-AML) is considered high risk as it related to prior exposure to cytotoxic chemotherapy agents for...

    Wenqiang Qu, Jialing Lu, ... Suning Chen in Cancer Chemotherapy and Pharmacology
    Article 02 March 2024
  4. Combination of menin and kinase inhibitors as an effective treatment for leukemia with NUP98 translocations

    Chromosomal translocations of the nucleoporin 98 ( NUP98 ) gene are found in acute myeloid leukemia (AML) patients leading to very poor outcomes. The...

    Hongzhi Miao, Dong Chen, ... Jolanta Grembecka in Leukemia
    Article 18 June 2024
  5. Causal linkage of presence of mutant NPM1 to efficacy of novel therapeutic agents against AML cells with mutant NPM1

    In AML with NPM1 mutation causing cytoplasmic dislocation of NPM1, treatments with Menin inhibitor (MI) and standard AML chemotherapy yield complete...

    Christopher P. Mill, Warren Fiskus, ... Kapil N. Bhalla in Leukemia
    Article Open access 28 March 2023
  6. Small Molecule Menin Inhibitors: Novel Therapeutic Agents Targeting Acute Myeloid Leukemia with KMT2A Rearrangement or NPM1 Mutation

    Recent advances have included insights into the clinical value of genomic abnormalities in acute myeloid leukemia (AML) and consequently the...

    Xavier Thomas in Oncology and Therapy
    Article Open access 01 February 2024
  7. Three-dimensional chromatin landscapes in MLLr AML

    Rearrangements of the mixed lineage leukemia (MLLr) gene are frequently associated with aggressive acute myeloid leukemia (AML). However, the...

    Pinpin Sui, Zhihong Wang, ... Feng Pan in Experimental Hematology & Oncology
    Article Open access 22 May 2024
  8. The Nup98::Nsd1 fusion gene induces CD123 expression in 32D cells

    The NUP98::NSD1 fusion gene is associated with extremely poor prognosis in patients with acute myeloid leukemia (AML). NUP98::NSD1 induces...

    Kenji Okamoto, Toshihiko Imamura, ... Tomoko Iehara in International Journal of Hematology
    Article 13 May 2023
  9. Identification of potential biomarkers of myopia based on machine learning algorithms

    Purpose

    This study aims to identify potential myopia biomarkers using machine learning algorithms, enhancing myopia diagnosis and prognosis prediction.

    ...
    Shengnan Zhang, Tao Wang, ... Chao Sun in BMC Ophthalmology
    Article Open access 22 September 2023
  10. SUV39H1 regulates the progression of MLL-AF9-induced acute myeloid leukemia

    Epigenetic regulations play crucial roles in leukemogenesis and leukemia progression. SUV39H1 is the dominant H3K9 methyltransferase in the...

    Ya**g Chu, Yangpeng Chen, ... Wei** Yuan in Oncogene
    Article Open access 09 October 2020
  11. P2X1 enhances leukemogenesis through PBX3-BCAT1 pathways

    How bone marrow niches regulate leukemogenic activities of leukemia-initiating cells (LICs) is unclear. The present study revealed that the metabolic...

    **aoxiao He, Yilu Xu, ... Junke Zheng in Leukemia
    Article Open access 23 November 2022
  12. The ENL YEATS epigenetic reader domain critically links MLL-ENL to leukemic stem cell frequency in t(11;19) Leukemia

    MLL (KMT2a) translocations are found in ~10% of acute leukemia patients, giving rise to oncogenic MLL-fusion proteins. A common MLL translocation...

    Hsiangyu Hu, Nirmalya Saha, ... Andrew G. Muntean in Leukemia
    Article 26 November 2022
  13. Genomic and global gene expression profiling in pediatric and young adult acute leukemia with PICALM::MLLT10 Fusion

    PICALM::MLLT10 fusion is a rare but recurrent genetic driver in acute leukemias. To better understand the genomic landscape of PICALM::MLLT10 (PM)...

    **gqun Ma, Yen-Chun Liu, ... Lu Wang in Leukemia
    Article 01 March 2024
  14. Requirement for LIM kinases in acute myeloid leukemia

    Acute myeloid leukemia (AML) is an aggressive disease for which only few targeted therapies are available. Using high-throughput RNA interference...

    Patrizia Jensen, Michela Carlet, ... Stefan Fröhling in Leukemia
    Article 26 June 2020
  15. The acidic stretch and the C-terminal nuclear export signal motif of NPM1 mutant: are they druggable in AML?

    Brunangelo Falini, Bjorn T. Gjertsen, Vibeke Andresen in Leukemia
    Article 22 September 2023
  16. Genetic and chemical targeting of the ATPase complex TIP48 and 49 impairs acute myeloid leukemia

    The chromatin-associated AAA+ ATPases Tip48 and Tip49 are the core components of various complexes implicated in diverse nuclear events such as DNA...

    Ayuna Hattori, Emi Takamatsu-Ichihara, ... Issay Kitabayashi in Leukemia
    Article 25 July 2023
Did you find what you were looking for? Share feedback.